| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | AF1002-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | AF938-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-43347-0.5mg | |||
| BSA Free | NBP1-43347-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | FAB1002A | |||
| Carrier Free | MAB1002-SP | |||
| Carrier Free | FAB1002V-100UG | |||
| Carrier Free | FAB1002U-100UG | |||
| Carrier Free | FAB1002T-100UG | |||
| Carrier Free | FAB1002S-100UG | |||
| Carrier Free | FAB1002R-100UG | |||
| Carrier Free | FAB1002N-100UG | |||
| Carrier Free | FAB1002G-100UG | |||
| Conjugate | Catalog # | Availability | Size | Price |
|---|---|---|---|---|
| Alexa Fluor 350 | FAB938U-100UG | |||
| Alexa Fluor 405 | FAB938V-100UG | |||
| Alexa Fluor 488 | FAB938G-100UG | |||
| Alexa Fluor 532 | FAB938X-100UG | |||
| Alexa Fluor 594 | FAB938T-100UG | |||
| Alexa Fluor 647 | FAB938R-100UG | |||
| Alexa Fluor 700 | FAB938N-100UG | |||
| Alexa Fluor 750 | FAB938S-100UG | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | MAB938-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-37420-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-43348-0.5mg | |||
| BSA Free | NBP1-43348-0.05mg | |||
![Immunocytochemistry/Immunofluorescence: VE Cadherin Antibody (BV9) [NB600-1409] - Endothelial cells were fixed with 4% PAF (15 min, room temp), and then permeabilized with 0.5% TritionX-100 (3 min, room temperature). Cells were incubated with a final concentration of 10mg/ml BV9. Secondary detection was performed with anti-mouse Alexa-Fluor 647 and counterstained using DAPI.](http://images.novusbio.com/fullsize/VE-Cadherin-Antibody-BV9-Immunocytochemistry-Immunofluorescence-NB600-1409-img0008.jpg "Immunocytochemistry/Immunofluorescence: VE Cadherin Antibody (BV9) [NB600-1409] - Endothelial cells were fixed with 4% PAF (15 min, room temp), and then permeabilized with 0.5% TritionX-100 (3 min, room temperature). Cells were incubated with a final concentration of 10mg/ml BV9. Secondary detection was performed with anti-mouse Alexa-Fluor 647 and counterstained using DAPI.")
![Flow Cytometry: VE Cadherin Antibody (BV9) [NB600-1409] - HUVEC cells were stained with antibody BV9 in PBS/0.1% saponin for 1h at 4 degrees C.(Black- no stain, Red- isotype control, Blue-HM2032-BV9)](http://images.novusbio.com/fullsize/VE-Cadherin-Antibody-BV9-Flow-Cytometry-NB600-1409-img0007.jpg)
![Western Blot: VE-Cadherin Antibody (BV14) [NBP1-43347] - Non-reduced (left) and reduced (right) bEnd.3 cell line lysates were loaded at 1x10^5 cells/lane, probed with 2 ug/mL of Anti-Mouse CD144 (VE-Cadherin) Purified and revealed with Anti-Rat IgG HRP.](http://images.novusbio.com/fullsize/VE-Cadherin-Antibody-BV14-Western-Blot-NBP1-43347-img0003.jpg "Western Blot: VE-Cadherin Antibody (BV14) [NBP1-43347] - Non-reduced (left) and reduced (right) bEnd.3 cell line lysates were loaded at 1x10^5 cells/lane, probed with 2 ug/mL of Anti-Mouse CD144 (VE-Cadherin) Purified and revealed with Anti-Rat IgG HRP.")
![N/A VE-Cadherin [HRP]](http://images.novusbio.com/fullsize2/DATA_VECadherin_DCADV0_ELISA_606.jpg "N/A VE-Cadherin [HRP]")
![Western Blot: VE-Cadherin Antibody (3D5C7) [NBP2-37420] - Western blot analysis using CDH5 mouse mAb against MCF-7 (1), A549 (2), HUVE-12 (3) cell lysate, and rat lung (4) tissue lysate.](http://images.novusbio.com/fullsize/VE-Cadherin-Antibody-3D5C7-Western-Blot-NBP2-37420-img0003.jpg "Western Blot: VE-Cadherin Antibody (3D5C7) [NBP2-37420] - Western blot analysis using CDH5 mouse mAb against MCF-7 (1), A549 (2), HUVE-12 (3) cell lysate, and rat lung (4) tissue lysate.")
![Flow Cytometry: VE-Cadherin Antibody (3D5C7) [NBP2-37420] - Flow cytometric analysis of Jurkat cells using CDH5 mouse mAb (green) and negative control (purple).](http://images.novusbio.com/fullsize/VE-Cadherin-Antibody-3D5C7-Flow-Cytometry-NBP2-37420-img0004.jpg)
![Western Blot: VE-Cadherin Antibody (3D5C7) [NBP2-37420] - Western blot analysis using CDH5 mAb against human CDH5 recombinant protein. (Expected MW is 47.6 kDa)](http://images.novusbio.com/fullsize/VE-Cadherin-Antibody-3D5C7-Western-Blot-NBP2-37420-img0002.jpg)
![ELISA: VE-Cadherin Antibody (3D5C7) [NBP2-37420] - Red: Control Antigen (100ng); Purple: Antigen (10ng); Green: Antigen (50ng); Blue: Antigen (100ng);](http://images.novusbio.com/fullsize/VE-Cadherin-Antibody-3D5C7-ELISA-NBP2-37420-img0001.jpg)
![Flow Cytometry: VE-Cadherin Antibody (BV13) [NBP1-43348] - Analysis using the Biotin conjugate of NBP1-43348. Staining of bEnd.3 cell line with 0.5 micrograms of Rat IgG1 k Isotype Control Biotin (blue histogram) or 0.125 micrograms of Anti-Mouse CD144 (VE-Cadherin) Biotin purple histogram) followed by Streptavidin PE. Total viable cells were used for analysis.](http://images.novusbio.com/fullsize/VE-Cadherin-Antibody-BV13-Flow-Cytometry-NBP1-43348-img0003.jpg "Flow Cytometry: VE-Cadherin Antibody (BV13) [NBP1-43348] - Analysis using the Biotin conjugate of NBP1-43348. Staining of bEnd.3 cell line with 0.5 micrograms of Rat IgG1 k Isotype Control Biotin (blue histogram) or 0.125 micrograms of Anti-Mouse CD144 (VE-Cadherin) Biotin purple histogram) followed by Streptavidin PE. Total viable cells were used for analysis.")
![Flow Cytometry: VE-Cadherin Antibody (BV13) [NBP1-43348] - Staining of bEnd.3 cell line with 0.5 ug of Rat IgG1 K Isotype Control Purified (open histogram) or 0.5 ug of AntiMouse CD144 (VE-Cadherin) Purified (filled histogram) followed by F(ab')2 Anti-Rat IgG PE. Total viable cells were used for analysis.](http://images.novusbio.com/fullsize/VE-Cadherin-Antibody-BV13-Flow-Cytometry-NBP1-43348-img0001.jpg)
![N/A VE-Cadherin [Biotin]](http://images.novusbio.com/fullsize2/DATA_VECadherin_DY93805_ELISA_2563.jpg "N/A VE-Cadherin [Biotin]")